Engineered Tissue Solutions (ETS)
Engineered Tissue Solutions (ETS) is an innovative company in the medical device industry, dedicated to supporting wound healing through cutting-edge borate-based bioactive glass technology.
ETS, headquartered in Rolla, Missouri, USA, specializes in developing medical products utilizing proprietary borate-based bioactive glass. Our flagship product, Mirragen®, represents a breakthrough in wound care technology as the first FDA-cleared inorganic bioactive glass-based solution.
Mirragen® is a flexible and formable skin substitute designed to seamlessly adapt to various wound beds. Constructed from natural elements, its porous fiber and microsphere structure efficiently absorb wound exudate, maintaining optimal moisture balance and providing essential support for the wound healing process.
Engineered to address a range of wound types*, from minor to complex, Mirragen® offers versatility and reliability. As a synthetic material, it can be conveniently stored at room temperature for up to five years, delivering a cost-effective solution for wound care needs.
*Partial and full-thickness wounds; Pressure ulcers; Venous ulcers; Diabetic ulcers; Surgical wounds (Donor sites/grafts, post-Mohs surgery, post-debridement, dehiscence); Trauma wounds (Abrasions, lacerations, first-and-second-degree burns, skin tears); Atypical wounds (Pyoderma gangrenosum, tunneling, undermining).
“Across every treatment area, medical technology is changing rapidly. The acquisition of Mo-Sci and ETS gives us new capabilities to help our customers deliver innovative technologies and breakthrough treatments that will improve outcomes and patient care.”
-Dr. Nicolas Guggenheim, President Heraeus Medical Technologies Business Area -
Management
